Private Markets Sector

Cursor, the agentic coding platform now being folded into SpaceX in a $60 billion all-stock deal, is using its newfound scale to launch a CFO Council rather than just close the transaction and move on—a savvy bit of ecosystem-building before the ink dries. The council, convening quarterly starting Aug. 18 in San Francisco, already counts CFOs from Natera, Payoneer, JFrog, Amplitude, SentinelOne, and Paytm, spanning both public tech names and legacy operators grappling with AI capex discipline. The subtext here is that private-market valuations for AI infrastructure plays are being underwritten increasingly by enterprise ROI narratives, not just top-line growth multiples—Cursor's own $60B tag depends on proving that agentic coding tools generate durable unit economics, not just engagement metrics. Internally, two of Cursor's ten most active users sit in finance, which tells you where the real adoption curve is bending inside AI-native firms, and where diligence teams should be looking for margin expansion. For allocators pricing similar late-stage AI rounds, this is a tell: governance and ROI frameworks are becoming a precondition for capital, not an afterthought bolted on post-close.

Innovaccer just crossed $200 million in annual recurring revenue, up from roughly $130 million a year ago—a 54% growth rate that's rare air for a healthcare infrastructure play and one that should reprice how private-market investors think about data-layer plumbing versus flashy AI application startups. The company has raised $675 million total, with its last $275 million round backed by B Capital, Danaher Ventures, Kaiser Permanente, and Microsoft's M12, and it now touches 80 million patient records across seven of the top ten U.S. health systems. Gartner just named it a leader in its inaugural healthcare technology Magic Quadrant, ranking it above Microsoft, Google, AWS, and Salesforce on vision and execution—a validation event that matters more for follow-on round pricing than any single customer win. The thesis, per CEO Abhinav Shashank, is that healthcare's $6 trillion spend includes roughly $1.5 trillion in pure administrative waste, and Innovaccer's customers already reported $2.5 billion in savings to regulators last year, mostly from care coordination rather than hardware. This is the opportunity-signal trade in private markets right now: unglamorous infrastructure with defensible data moats is outperforming application-layer AI hype, and late growth-equity checks are following the ARR curve rather than the buzz.

Corgi is raising a third round in eight weeks, reportedly at a $4 billion valuation — up from $2.6 billion in late May and $1.3 billion in early May, a 3x in under two months that makes even AI-cycle comps look pedestrian. The justification is revenue, not vibes: sources tell Forbes annualized run-rate is tracking toward $450 million by year-end, up from $40 million when the Series A closed in January. But Corgi underwrites insurance through a Risk Retention Group structure, meaning claims are paid from a shared pool with no state guaranty backstop — a single large claim can drain the kitty for everyone in it. Layer on a data-room software business (recently dinged for vibe-coded quality issues) and an expanding footprint of 24-hour coffee shops, and the cash-burn math starts looking less like insurtech discipline and more like a capital-intensive conglomerate wearing a SaaS multiple. TCV and Kindred Ventures are underwriting the story at each step, but the gap between markup velocity and underwriting-cycle reality is the kind of thing that eventually gets marked back down hard.